Table 4.
FibroDetect score | Investigational group | Control group | |||||||
---|---|---|---|---|---|---|---|---|---|
ACR + (N = 137) | ACR– (N = 139) | FM (N = 158) | Non-FM (N = 154) | ||||||
FibroDetect score | N | 129 | 133 | 153 | 148 | ||||
Mean (SD) | 6.8 (1.9) | 5.1 (1.9) | 7.6 (1.5) | 4.7 (2.1) | |||||
Median (Q1 - Q3) | 7.0 (6.0 - 8.0) | 5.0 (4.0 - 6.0) | 8.0 (7.0 - 9.0) | 5.0 (3.0 - 6.0) | |||||
Min – Max | 2.0 - 9.0 | 1.0 - 9.0 | 2.0 - 9.0 | 0.0 - 9.0 | |||||
Thresholds 1 | ≤ 3 - N (%) | 11 | (8.5) | 28 | (21.1) | 4 | (2.6) | 47 | (31.8) |
4-5 - N (%) | 19 | (14.7) | 53 | (39.8) | 12 | (7.8) | 52 | (35.1) | |
≥ 6 - N (%) | 99 | (76.7) | 52 | (39.1) | 137 | (89.5) | 49 | (33.1) |
1Missing data were not included in the calculation of percentages.